# Immunocore Holdings plc: filings

IMCR · Nasdaq · CIK 1671927 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imcr.md) · [Financials](/companies/imcr/financials.md) · [Filings](/companies/imcr/filings.md) · [Insiders](/companies/imcr/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 46, 6-K 40, 8-K 33, 144 28, 3 15, SC 13G/A 12, SCHEDULE 13G/A 12, SC 13G 11, 10-Q 8, SC 13D/A 8, CORRESP 6, S-8 6, SCHEDULE 13G 5, 424B7 4, 10-K 3, 20-F 3, ARS 3, DEF 14A 3, SEC STAFF LETTER 3, UPLOAD 3, CERT 2, DRS/A 2, EFFECT 2, F-1/A 2, PRE 14A 2, SC 13D 2, 424B4 1, 424B5 1, 6-K/A 1, 8-A12B 1, D 1, DRS 1, F-1 1, F-1MEF 1, F-3ASR 1, F-6 1, F-6/A 1, POSASR 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-14 | 11:15 ET | [8-K](/filings/0001671927-26-000026.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001671927-26-000026 |
| 2026-08-06 | 11:05 ET | [10-Q](/filings/0001671927-26-000022.md) | Quarterly report, period 2026-06-30 | 0001671927-26-000022 |
| 2026-08-06 | 11:01 ET | [8-K](/filings/0001671927-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001671927-26-000020 |
| 2026-05-27 | 20:21 ET | [8-K](/filings/0001140361-26-022984.md) | 5.07 Shareholder vote results | 0001140361-26-022984 |
| 2026-05-06 | 11:09 ET | [8-K](/filings/0001140361-26-019205.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-019205 |
| 2026-05-06 | 11:01 ET | [10-Q](/filings/0001671927-26-000009.md) | Quarterly report, period 2026-03-31 | 0001671927-26-000009 |
| 2026-04-16 | 20:05 ET | [DEF 14A](/filings/0001140361-26-015122.md) | Proxy statement, period 2026-05-27 | 0001140361-26-015122 |
| 2026-02-25 | 12:30 ET | [8-K](/filings/0001140361-26-006721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-006721 |
| 2026-02-25 | 12:01 ET | [10-K](/filings/0001671927-26-000005.md) | Annual report, period 2025-12-31 | 0001671927-26-000005 |
| 2026-01-30 | 12:22 ET | [8-K](/filings/0001140361-26-002894.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-002894 |
| 2026-01-09 | 12:11 ET | [8-K](/filings/0001140361-26-000780.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-000780 |
| 2025-11-28 | 12:01 ET | [8-K](/filings/0001140361-25-043600.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-043600 |
| 2025-11-06 | 12:31 ET | [8-K](/filings/0001140361-25-040664.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-040664 |
| 2025-11-06 | 12:00 ET | [10-Q](/filings/0001671927-25-000018.md) | Quarterly report, period 2025-09-30 | 0001671927-25-000018 |
| 2025-08-07 | 11:40 ET | [8-K](/filings/0001140361-25-029350.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-029350 |
| 2025-08-07 | 11:01 ET | [10-Q](/filings/0001671927-25-000014.md) | Quarterly report, period 2025-06-30 | 0001671927-25-000014 |
| 2025-05-15 | 20:12 ET | [8-K](/filings/0001140361-25-019282.md) | 5.07 Shareholder vote results | 0001140361-25-019282 |
| 2025-05-07 | 11:33 ET | [8-K](/filings/0001140361-25-017615.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017615 |
| 2025-05-07 | 11:00 ET | [10-Q](/filings/0001671927-25-000009.md) | Quarterly report, period 2025-03-31 | 0001671927-25-000009 |
| 2025-04-04 | 10:05 ET | [DEF 14A](/filings/0001140361-25-012123.md) | Proxy statement, period 2025-05-15 | 0001140361-25-012123 |
| 2025-03-17 | 12:18 ET | [8-K](/filings/0001140361-25-008918.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-008918 |
| 2025-03-10 | 20:17 ET | [8-K](/filings/0001140361-25-007867.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-007867 |
| 2025-02-26 | 12:22 ET | [8-K](/filings/0001140361-25-005988.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-005988 |
| 2025-02-26 | 12:00 ET | [10-K](/filings/0001671927-25-000006.md) | Annual report, period 2024-12-31 | 0001671927-25-000006 |
| 2025-01-10 | 21:26 ET | [8-K](/filings/0001140361-25-000837.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-000837 |
| 2025-01-02 | 12:33 ET | [8-K](/filings/0001140361-25-000008.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-000008 |
| 2024-11-08 | 21:20 ET | [8-K](/filings/0001140361-24-045855.md) | 1.02 Termination of a material agreement | 0001140361-24-045855 |
| 2024-11-06 | 12:22 ET | [8-K](/filings/0001140361-24-045343.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-045343 |
| 2024-11-06 | 12:00 ET | [10-Q](/filings/0001671927-24-000011.md) | Quarterly report, period 2024-09-30 | 0001671927-24-000011 |
| 2024-09-16 | 10:46 ET | [8-K](/filings/0001140361-24-041100.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-041100 |
| 2024-08-29 | 11:21 ET | [8-K](/filings/0001140361-24-039083.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-039083 |
| 2024-08-08 | 11:21 ET | [8-K](/filings/0001140361-24-036283.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036283 |
| 2024-08-08 | 11:06 ET | [10-Q](/filings/0001671927-24-000005.md) | Quarterly report, period 2024-06-30 | 0001671927-24-000005 |
| 2024-05-31 | 20:21 ET | [8-K](/filings/0001140361-24-028366.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-028366 |
| 2024-05-30 | 21:22 ET | [8-K](/filings/0001140361-24-028194.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-028194 |
| 2024-05-28 | 20:17 ET | [8-K](/filings/0001140361-24-027667.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-027667 |
| 2024-05-23 | 20:50 ET | [8-K](/filings/0001140361-24-027312.md) | 5.07 Shareholder vote results | 0001140361-24-027312 |
| 2024-05-08 | 11:13 ET | [8-K](/filings/0001140361-24-024789.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-024789 |
| 2024-05-08 | 11:00 ET | [10-Q](/filings/0001140361-24-024784.md) | Quarterly report, period 2024-03-31 | 0001140361-24-024784 |
| 2024-04-12 | 20:20 ET | [DEF 14A](/filings/0001140361-24-019623.md) | Proxy statement, period 2024-05-23 | 0001140361-24-019623 |
| 2024-04-05 | 20:35 ET | [8-K](/filings/0001140361-24-018342.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-018342 |
| 2024-03-07 | 02:45 ET | [SC 13D/A](/filings/0000950142-24-000652.md) | Ownership report, active investor, amended | 0000950142-24-000652 |
| 2024-02-28 | 21:19 ET | [8-K](/filings/0001140361-24-010098.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-010098 |
| 2024-02-28 | 12:33 ET | [10-K](/filings/0001140361-24-009921.md) | Annual report, period 2023-12-31 | 0001140361-24-009921 |
| 2024-02-02 | 21:05 ET | [8-K](/filings/0001140361-24-005309.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-005309 |
| 2024-02-01 | 22:25 ET | [SC 13D/A](/filings/0001104659-24-009526.md) | Ownership report, active investor, amended | 0001104659-24-009526 |
| 2024-01-29 | 22:06 ET | [8-K](/filings/0001140361-24-004321.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-004321 |
| 2024-01-05 | 12:19 ET | [8-K](/filings/0001140361-24-000832.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-000832 |
| 2024-01-02 | 11:25 ET | [8-K](/filings/0001140361-24-000012.md) | 7.01 Regulation FD disclosure | 0001140361-24-000012 |
| 2023-11-07 | 12:09 ET | [6-K](/filings/0001140361-23-051708.md) | Report of a foreign private issuer, period 2023-11-07 | 0001140361-23-051708 |

Page 1 of 2. [Older](/companies/imcr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.